INS and type 2 diabetes mellitus: The results from this research strongly suggests that selection of animal model for T2D studies should be based on circulating endogenous serum insulin of not less than 85.7% of normal control groups in a hyperglycaemic condition of non-fasting blood glucose ≥300mg/dL.